Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Functional Analysis of BRCAness [Phase 2]
Phase 2 clinical trial evaluating functional analysis of BRCAness in epithelial ovarian cancer with homologous recombination deficiency (ass…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Hysterectomy and OPPortunistic SAlpingectomy [NA]
Göteborg University reports a clinical trial on hysterectomy with opportunistic salpingectomy for ovarian cancer complications; the study is…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]
This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]
TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors [NA]
Clinical trial update on SY001, a mesothelin-targeting therapy, tested in a single-arm, dose-escalation study in subjects with advanced soli…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) [Phase 3]
Phase 3 clinical trial update on interval cytoreductive surgery with or without HIPEC for ovarian cancer (FOCUS / KOV-HIPEC-04), currently r…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
This clinical trial update reports that data collection is ongoing for patients with low-grade ovarian and peritoneal tumors, with recruitme…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy [EARLY_Phase 1]
This early-phase study is evaluating the effects of a probiotic intervention on the gut and vaginal microbiomes in patients with advanced or…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy [Phase 2]
This Phase II randomized, open-label trial evaluates whether NiraParib maintenance after 3 cycles of platinum-based chemotherapy is non-infe…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) [Phase 3]
Phase 3 trial evaluating cytoreductive surgery with HIPEC using mitomycin C for platinum-resistant recurrent epithelial ovarian cancer is cu…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer [Phase 2]
A Phase 2 neoadjuvant trial in advanced ovarian cancer evaluating iparomlimab and tuvonralimab (QL1706) with either standard chemotherapy or…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]
Phase 1 study update for NRM-823 in locally advanced or metastatic refractory solid tumors, currently recruiting. The trial lists head and n…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer [Phase 2]
A Phase 2 immunotherapy platform trial in platinum-resistant high-grade serous ovarian cancer is currently recruiting under the Canadian Can…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy
AbbVie-sponsored clinical study in Italy to evaluate folate receptor alpha expression in adults with ovarian, fallopian tube, or primary per…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial is evaluating the combination of lenvatinib, pembrolizumab, and paclitaxel for recurrent endometrial, ovarian, fallopian …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer [EARLY_Phase 1]
This is a Phase 1 trial evaluating hyperthermic intraperitoneal chemotherapy with cisplatin during or before surgery for Stage III/IV ovaria…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS [NA]
This clinical trial update outlines sequential profiling of tumor-derived circulating cell-free DNA (ctDNA) in patients with advanced ovaria…
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs [NA]
A clinical trial evaluating an individual decision aid for colorectal, breast, and ovarian cancer screening in Sweden has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma [Phase 1]
Phase 1 trial update for SynKIR-110 in mesothelin-expressing ovarian cancer, cholangiocarcinoma, and mesothelioma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer [NA]
A completed clinical trial evaluating delaying surgery after neoadjuvant chemotherapy in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations [NA]
A completed clinical trial evaluated whether a video-based intervention helps participants persuade family members to undergo BRCA1/BRCA2 ge…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression [Phase 2]
This Phase 2 clinical trial compares paclitaxel monotherapy to paclitaxel plus carboplatin as neoadjuvant chemotherapy in patients with adva…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
A recruiting clinical trial from University Hospital Tuebingen is studying immunotherapy-related CRP kinetics in metastatic gynecological ca…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…